MedTrace Logo

Zinc Supplementation in Pediatric Sepsis

NCT05366595 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2023-03-03

No results posted yet for this study

Summary

a single blinded randomized controlled clinical trial that was conducted to evaluate the role of zinc supplementation in improving the outcome of infants and children with sepsis in pediatric intensive care unit.

Conditions

  • Zinc in Pediatric Sepsis

Interventions

DRUG

oral zinc sulfate

Oral zinc sulfate at dose 10 to 20 mg daily for 10 days

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Angi A Al Wakil, MD · Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
2 Months
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-31
Primary Completion
2022-06-10
Completion
2022-08-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05366595 on ClinicalTrials.gov